| Report ID | 282110 |
| Drug Identification Number | 02491915 |
| Brand name | LUPIN-PROPRANOLOL LA |
| Common or Proper name | LUPIN-PROPRANOLOL LA |
| Company Name | LUPIN PHARMA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | PROPRANOLOL HYDROCHLORIDE |
| Strength(s) | 120MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C07AA |
| ATC description | BETA BLOCKING AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2026-04-02 |
| Estimated end date | 2026-07-15 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-04-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 550-1111 RUE ST-CHARLES OUEST LONGUEUIL, QUEBEC CANADA J4K 5G4 |
| Company contact information | [email protected] (Customer service / Service à la clientèle) |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-04-02 | French | Compare |
| v1 | 2026-04-02 | English | Compare |
Showing 1 to 2 of 2